Ask AI
ProCE Banner Activity

Experts Highlight the Most Important Advances in HR+/HER2- Breast Cancer

Slideset

Download these expert-curated slides covering the evidence underlying the most important, clinically relevant recent advances in the management of patients with early and advanced HR+/HER2- breast cancer with a look ahead to expected new evidence that may change practice in the coming year.

Released: April 25, 2025

Expiration: October 24, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Lilly and Stemline Therapeutics, Inc.

Lilly

Stemline Therapeutics, Inc.